Kidney Function, ACE-Inhibitor/Angiotensin Receptor Blocker Use, and Survival Following Hospitalization for Heart Failure: A Cohort Study
Background: Angiotensin-converting enzyme inhibitors/angiotensin receptor blocker (ACE-I/ARB) improve outcomes in patients with heart failure and reduced left-ventricular (LV) systolic function. However, these medications can cause a rise in serum creatinine and their benefits in patients with HF ac...
Main Authors: | Michael H. Chiu, Robert J. H. Miller, Rebecca Barry, Bing Li, Bryan J. Har, Stephen B. Wilton, Merril Knudtson, Jonathan G. Howlett, Matthew T. James |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-10-01
|
Series: | Canadian Journal of Kidney Health and Disease |
Online Access: | https://doi.org/10.1177/2054358118804838 |
Similar Items
-
Interaction of -blockers and angiotensin receptor blockers/ACE inhibitors in heart failure
by: Jay N Cohn
Published: (2003-09-01) -
Comparing recommended doses of angiotensin receptor blockers and ACE inhibitors (CORD Study)
by: J. Spinar, et al.
Published: (2009-08-01) -
Review: Effect of combining angiotensin receptor blockers and ACE inhibitors on cardiovascular disease
by: Trefor Morgan
Published: (2001-03-01) -
Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function
by: Bo-qing Zhu, et al.
Published: (2003-03-01) -
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers
by: Neil Poulter, et al.
Published: (2006-06-01)